Press release
Latest Guidebook for Review and Approval Procedures of Overseas Imported New Drugs for Chinese Clinical Urgent Demand (2019 Edition) – Supply Demand Market Research
In recent years, China’s fast-track approval time is much shorter than any other country, which attracts more and more overseas pharmaceutical manufacturers to enter into the Chinese healthcare market. Undoubtedly the Chinese healthcare market of nearly 1.4 billion populations is a huge business opportunities for the overseas pharmaceutical manufacturers.
Download Sample PDF copy of this report @ https://www.supplydemandmarketresearch.com/home/contact/587765?ref=Sample-and-Brochure&toccode=SDMRRE587765
China is one of the fastest growing global economies with one fifth population in the world. Nowadays, China has become the world's second largest healthcare market after the United States. Facing a gigantic population and rapid population aging, the Chinese government accelerated the priority approval of innovative drugs and relaxed the market access for overseas drugs to cope with the clinical urgent demand.
The Chinese “National Medical Products Administration (NMPA)” and the “National Health Commission (NHC)” jointly issued the latest “Review and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand” on October 23, 2018, which provided a dedicated pathway for priority review and approval of overseas drugs importing to Chinese healthcare market and clarified the specific review and approval procedures.
To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of Chinese healthcare market, how do the foreign pharmaceutical manufacturers in compliance with the latest “Review and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand”? How do the overseas pharmaceutical manufacturers operate business smoothly in China? The overseas and multinational pharmaceutical manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the latest regulations for priority review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand. The Chinese regulatory approach is unique.
The audiences of this guidebook are the overseas pharmaceutical manufacturers wishing to enter into the Chinese healthcare market, and the multinational pharmaceutical manufacturers have penetrated into the Chinese healthcare market, as well as their senior executive officers engaging in regulatory affairs expecting to understand the latest regulations on review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand. After having skimmed through this guidebook, audiences can clearly acquire a comprehensive and thorough knowledge of the latest regulations on priority review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand. Access China Management Consulting Ltd hopes this guidebook, based on the full and accurate regulations, can guide the overseas and multinational pharmaceutical manufacturers to achieve a successful entry into the Chinese healthcare market, and smoothly operate their companies in China.
The Chinese “National Medical Products Administration (NMPA)” and the “National Health Commission (NHC)” jointly issued the latest “Review and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand” on October 23, 2018, which provided a dedicated pathway for priority review and approval of overseas drugs importing to Chinese healthcare market and clarified the specific review and approval procedures. This is a huge business opportunities for the overseas pharmaceutical manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of Chinese healthcare market, how do the foreign pharmaceutical manufacturers in compliance with the latest “Review and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand”? How do the overseas pharmaceutical manufacturers operate business smoothly in China? The overseas and multinational pharmaceutical manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the latest regulations for review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand. The Chinese regulatory approach is unique.
Enquire before purchase@: https://www.supplydemandmarketresearch.com/home/purchase?code=SDMRRE587765
Table of Contents:
Chapter 1 Executive Summary.
Chapter 2 China’s Changing Healthcare Market Landscape and Rapidly Changing Regulatory FraChapter 3 Scope of Drug Variety for Review and Approval Procedures of Overseas Imported NeChapter 4 Drug Variety Selection.
Chapter 5 Review and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand.
Chapter 6 Requirements for Application Materials.
Chapter 7 Overseas Applicants' Duties and Obligations for Drugs on Post-marketing in China.
…….TOC Continued
Canada Office:
302-20 Misssisauga Valley Blvd, Missisauga, L5A 3S1, Toronto
Contact Us
Email- info@supplydemandmarketresearch.com
Website- www.supplydemandmarketresearch.com
Phone Number: +919960204545
About us
We have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis.
Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Latest Guidebook for Review and Approval Procedures of Overseas Imported New Drugs for Chinese Clinical Urgent Demand (2019 Edition) – Supply Demand Market Research here
News-ID: 1832223 • Views: …
More Releases from Supply Demand Market Research
South Korea Flounder Market Anticipated to grow at a CAGR of 8% from 2023-2030
The South Korea flounder is anticipated to grow at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin B1 and B2, which is effective…
Global Flounder Market Anticipated to reach USD 56 Billion by 2030
The global flounder market is anticipated to reach USD 56 Billion by 2030, growing at a CAGR% of 8.0% from 2022-2030. The factors contributing towards the high growth are flounders such as halibut and turbot high-protein and low-calorie food, helps to re-solve the nutritional imbalance from diet because of its rich minerals, carbohydrates and vitamins despite low-calorie. They also offer medical benefits as liver of halibut contains lots of vitamin…
Global Seafood Market Anticipated to reach USD 730 Billion by 2030
The global seafood market is anticipated to reach USD 730 Billion by 2030, growing at a CAGR% of 8.9% from 2022-2030. The factors contributing towards the high growth are increased disposable income, awareness of fish being used as an ingredient in healthy food is growing. USA the government plans to sanction illegal fishing activities, actively promote fair trade, and promote strategies to promote the fishing industry through detailed strategies such…
Robotic Palletizers Market Is Expected to Reach US$11.98 Billion by 2033
The global robotic palletizers market is anticipated to reach $11.98 billion by 2033, presenting a 2023-2033 CAGR of 8.3%. The factors contributing towards the growth include the emerging Industry 4.0, a large scope for AI innovation, an increasing adoption of advanced industrial robotics to improve productivity and safety in manufacturing sectors, and the increasing government initiatives.
The report is highlighted with 122 tables and 96 figures, this 209-page report "Global Robotic…
More Releases for Chinese
Gao Yuan at UN Chinese Language Day: Bridging Cultures Through Traditional Chine …
On April 20, 2025, CCTV host Gao Yuan participated in the UN Chinese Language Day celebrations at the United Nations Headquarters in New York, showcasing the profound heritage and innovative vitality of traditional Chinese arts to a global audience.
Image: https://www.globalnewslines.com/uploads/2025/04/556563a6bf5cb3de8982c8ef94cb6380.jpg
During the thematic forum "Civilizational Dialogue and Artistic Symbiosis," Gao Yuan moderated a cultural salon titled "Digital Technology Empowers Traditional Arts." She highlighted China's recent efforts to reinterpret calligraphy and ink…
The TV program "Chinese Practice with Chinese Wisdom" Officially Airs: The Endur …
Chinese Practice with Chinese Wisdom is a 10-episode TV program produced by Jiangsu Broadcasting Corporation, one of the most influential media groups in China. It gives a vivid presentation of traditional Chinese cultural elements such as poetry, calligraphy, seal-cutting, traditional Chinese operas, dance, and martial arts, aiming to enrich audiences with cultural enlightenment and aesthetic enjoyment. Through questions, disucssions, elaborations, feelings, and stories shared by guests from around the world,…
Chinese Fenjiu Shines at SCWC Conference, Bridging Chinese Liquor and Western Cu …
Fenjiu Debuts at the International Stage, Blending Tradition, Innovation, and Cultural Fusion, while Captivating Global Food and Beverage Experts.
Barcelona, Spain - November 22, 2024 - Fenjiu, a premier Chinese liquor brand, made a landmark appearance at the Science and Cooking World Congress (SCWC) in Barcelona, Spain. Renowned for its light-fragrance style and rich cultural heritage, Fenjiu captivated global food and beverage professionals as it showcased its unique blend of tradition,…
Online Chinese Language School
Taiwan Chinese Education Center is an online Chinese language school.
You can learn Chinese one-on-one from the best Chinese teachers in Taiwan.
We opened our school in Japan in 2010 and have over 12 years of rich experience in online Mandarin teaching.
In November 2022, we started Mandarin education service for people in Europe, America, and other countries.
Chinese is the world's No. 1 native language, spoken by about 15% of the world's population.
About…
Chinese Investors Look Abroad
Beijing, China July 30, 2012 – An Outbound Investment Seminar hosted by Chance & Bridge Partners drew a large audience of investors, Chinese SMEs, and international partner law firms.
Many Chinese investors and companies are looking to diversify their holdings and enter new markets. This has led to an increase in cross-border investment, banking, consulting, and legal services for the Chinese clients. Many of these areas were addressed during the…
Introducing A New Chinese Reader to Enable Chinese Language Students to Master C …
Capturing Chinese presents a new advanced Chinese reader helping students master the literature of China's best authors. Allowing students to put down their dictionaries and instead curl up with a book of Chinese literature, Capturing Chinese is a must have for intermediate and advanced Chinese language students.
The new book, titled Capturing Chinese Stories: Prose and Poems by Revolutionary Authors, features five of the most influential authors in recent Chinese history…
